Could mailing HPV tests boost cancer screening?

NCT ID NCT06674681

Recruiting now Diagnosis Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to make cervical cancer screening more convenient by offering HPV self-collection kits that women can use at home or in the clinic. Researchers will enroll 1,000 women aged 25-65 who are overdue for screening. The goal is to see how many women complete the test and follow up on positive results, helping clinics implement this option more effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HPV self-collection kit
What this could lead to: If successful, this program could make cervical cancer screening more accessible and convenient, potentially increasing screening rates and catching more cases early.
What could go wrong: This is an implementation study, not a test of the test itself. It focuses on logistics and uptake, so it won't directly prove the self-collection method detects cancer better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV

Contacts and locations

Locations

University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences
RECRUITING

Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.